- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2364-1746
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Emerging Biological Therapies in Severe Eosinophilic Asthma ; day:18 ; month:8 ; year:2016 ; pages:1-17
Pulmonary therapy ; (18.8.2016), 1-17
- Urheber
-
Hay, Bryan R.
- Beteiligte Personen und Organisationen
-
Risaliti, Carleen M.
McCallister, Jennifer W.
SpringerLink (Online service)
- DOI
-
10.1007/s41030-016-0019-x
- URN
-
urn:nbn:de:1111-2016091515336
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hay, Bryan R.
- Risaliti, Carleen M.
- McCallister, Jennifer W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Eosinophilic bioactivities in severe asthma
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Emerging therapies for severe asthma
Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
Biological therapy for severe asthma
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Quality of life and work functionality in severe asthma patients: the impact of biological therapies
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Eosinophilic bioactivities in severe asthma
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Emerging therapies for severe asthma
Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
Biological therapy for severe asthma
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Quality of life and work functionality in severe asthma patients: the impact of biological therapies
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Eosinophilic bioactivities in severe asthma
Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
Emerging therapies for severe asthma
Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
Biological therapy for severe asthma
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
Quality of life and work functionality in severe asthma patients: the impact of biological therapies
Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis